Ikuko Kato

Dr. Ikuko Kato

Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2016 in Journal of the American College of Nutrition
Verified
Journal Article
Closed access
IKIkuko Kato
Ikuko Kato
AVAdrian Vasquez
Adrian Vasquez
GMGregory Moyerbrailean
Gregory Moyerbrailean
SLSusan Land
Susan Land
ZDZora Djuric
Zora Djuric
JRJeffrey L. Ram
Jeffrey L. Ram
Background: Despite many potential effects of the oral microbiome on oral and systemic health, scant information is available regarding the associations between diet and the oral microbiome. Methods: Oral rinse DNA samples from 182 participants in a population-based case–control study for colorectal cancer were used to amplify a V3–V4 region of bacterial 16S rRNA gene. The amplicons were sequenced using Illumina MiSeq paired end chemistry on 2 runs, yielding approximately 33 million filtered reads that were assigned to bacterial classes. Relative abundances of each class and family as well microbial diversity/richness indices were correlated with selected dietary intakes from a food frequency questionnaire. Results: Saturated fatty acids (SFAs) and vitamin C intakes were consistently correlated with alpha (within-subjects) diversity indexes in both richness and diversity. SFA intake was positively correlated with relative abundance of betaproteobacteria and fusobacteria. Vitamin C and other vitamins with correlated intakes—for example, the B vitamins and vitamin E—exhibited positive correlations with fusobacteria class, its family Leptotrichiaceae and a clostridia family Lachnospiraceae. In addition, glycemic load was positively correlated with Lactobacillaceae abundance. Conclusion: The observed associations in this study were modest. However, the results suggest that the effects of diets are likely to be habitat specific, and observations from the gut microbiome are not transferrable to the oral microbiome. Further studies are warranted, incorporating a range of host biomarkers, such as cytohistological, molecular, or biochemical measurements, in order to address biological consequences of these dietary intakes in human oral health.

23 October 2011 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
SSSeema Sethi
Seema Sethi
RARouba Ali‐Fehmi
Rouba Ali‐Fehmi
SFSilvia Franceschi
Silvia Franceschi
LSLinda Struijk
Linda Struijk
LDLeen‐Jan van Doorn
Leen‐Jan van Doorn
IKIkuko Kato
Ikuko Kato
Elucidation of the role of human papillomavirus (HPV) in the etiology and prognosis of squamous carcinomas of the head and neck (HNSCC) is essential to optimize prevention and treatment strategies for this disease. We analyzed 385 HNSCC tissue blocks identified through a population‐based cancer registry in Metropolitan Detroit for HPV DNA using a broad‐spectrum PCR technique (SPF10‐LiPA25) to correlate with patient and tumor characteristics and overall survival. Overall, HPV DNA (any type) was detected in 29.4% of all HNSCC, but it was significantly more prevalent (50.6%) in oropharyngeal sites (N = 81), where 90% of HPV were type 16, than in other sites. HPV prevalence (any type) in oropharyngeal sites was highest in patients with a negative smoking indicator, Caucasians and in regional tumor stage. Likewise, only in oropharyngeal sites did patients overall positive to HPV show significantly better survival compared with HPV‐negative patients, notably among those who had been irradiated. The best and the worst survival from cancer in oropharyngeal sites were found, respectively, among HPV‐positive patients with negative smoking indicator and among HPV‐negative patients with positive smoking indicator. The results of this study revealed that the presence of HPV DNA was associated with patients' specific characteristics and better overall survival exclusively in oropharyngeal sites. To define the fraction of HNSCC preventable by HPV vaccination or amenable to less aggressive treatment, however, tobacco exposure and HPV markers other than DNA presence need to be taken into account.

3 December 2015 in Journal of Epidemiological Research
Verified
Journal Article
Closed access
PDF file
IKIkuko Kato
Ikuko Kato
AVAdrian A. Vasquez
Adrian A. Vasquez
GMGregory Moyerbrailean
Gregory Moyerbrailean
SLSusan Land
Susan Land
JSJun Sun
Jun Sun
JRJeffrey L. Ram
Jeffrey L. Ram
Oral microbiome and history of smoking and colorectal cancer

6 July 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
RLRong Lu
Rong Lu
MBMaarten Bosland
Maarten Bosland
YXYinglin Xia
Yinglin Xia
YZYong-Guo Zhang
Yong-Guo Zhang
IKIkuko Kato
Ikuko Kato
JSJun Sun
Jun Sun
Presence of Salmonella AvrA in colorectal tumor and its precursor lesions in mouse intestine and human specimens Presence of Salmonella AvrA in colorectal tumor and its precursor lesions in mouse intestine and human specimens

29 April 2019 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
CRCosmeri Rizzato
Cosmeri Rizzato
JTJavier Torres
Javier Torres
EKElena Kasamatsu
Elena Kasamatsu
MCMargarita Camorlinga-Ponce
Margarita Camorlinga-Ponce
MBMaria Mercedes Bravo
Maria Mercedes Bravo
IKIkuko Kato
Ikuko Kato
Bacteria are highly social organisms that communicate via signaling molecules and can assume a multicellular lifestyle to build biofilm communities. Until recently, complications from biofilm-associated infection have been primarily ascribed to increased bacterial resistance to antibiotics and host immune evasion, leading to persistent infection. In this theory and hypothesis article we present a relatively new argument that biofilm formation has potential etiological role in the development of digestive tract cancer. First, we summarize recent new findings suggesting the potential link between bacterial biofilm and various types of cancer to build the foundation of our hypothesis. To date, evidence has been particularly convincing for colorectal cancer and its precursor, i.e., polyps, pointing to several key individual bacterial species, such as Bacteroides fragilis, Fusobacterium nucleatum, and Streptococcus gallolyticus subsp. Gallolyticus. Then, we further extend this hypothesis to one of the most common bacterial infection in humans, Helicobacter pylori (Hp), which is considered a major cause of gastric cancer. Thus far, there has been no direct evidence linking in vivo Hp gastric biofilm formation to gastric carcinogenesis. Yet, we synthesize the information to support an argument that biofilm associated-Hp is potentially more carcinogenic, summarizing biological characteristics of biofilm-associated bacteria. We also discuss mechanistic pathways as to how Hp or other biofilm-associated bacteria control biofilm formation and highlight recent findings on Hp genes that influence biofilm formation, which may lead to strain variability in biofilm formation. This knowledge may open a possibility of developing targeted intervention. We conclude, however, that this field is still in its infancy. To test the hypothesis rigorously and to link it ultimately to gastric pathologies (e.g., premalignant lesions and cancer), studies are needed to learn more about Hp biofilms, such as compositions and biological properties of extracellular polymeric substance (EPS), presence of non-Hp microbiome and geographical distribution of biofilms in relation to gastric gland types and structures. Identification of specific Hp strains with enhanced biofilm formation would be helpful not only for screening patients at high risk for sequelae from Hp infection, but also for development of new antibiotics to avoid resistance, regardless of its association with gastric cancer.

10 October 2001 in Cancer
Verified
Journal Article
Open access
PDF file
IKIkuko Kato
Ikuko Kato
RSRichard K. Severson
Richard K. Severson
ASAnn G. Schwartz
Ann G. Schwartz
BACKGROUND Conditional survival is clinically useful, particularly for patients with malignant disease who have a poor prognosis. However, there are no published data on the conditional median survival of patients with advanced carcinoma on a population basis. METHODS Data on 217,573 patients with breast, colorectal, lung, or prostate carcinoma who were newly diagnosed with distant disease between 1973 and 1995 and who were followed through the end of 1997 were extracted from the Surveillance, Epidemiology, and End Results (SEER) data base of the National Cancer Institute. The Kaplan–Meier method was employed to estimate conditional median survival and 95% confidence intervals at 0–5 years after the initial diagnosis. RESULTS The conditional median survival increased as time elapsed after the initial diagnosis. The increase was slowest and almost leveled off among patients with prostate carcinoma. The median survival of patients with breast carcinoma increased relatively linearly with time, i.e., 5–6 months per year. Conversely, there was a rapid increase in the conditional median survival according to the amount of time since diagnosis for patients with lung and colorectal carcinoma. The trend was most pronounced for patients with colorectal carcinoma. At 5 years after the initial diagnosis, the remaining median survival was longest for patients with colorectal carcinoma, almost 6 years (71.5 months), followed by patients with lung carcinoma (52.5 months), breast carcinoma (42.5 months), and prostate carcinoma (34.5 months). Although race was a correlate with initial survival, gender and age had more impact on late conditional survival. CONCLUSIONS The conditional median survival provides useful and encouraging information for patients who survive with advanced disease and for healthcare professionals who treat these patients. However, the information should be used carefully, taking the limitations of these data into account. Cancer 2001;92:2211–9. © 2001 American Cancer Society.